Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

Cost Saving: The trade-off that bites back

Posted on April 3rd, 2017 by in Pharma R&D

Making a trade-off between competing activities or priorities is a critical skill involved in developing a new medicine. This approach helps balance the risk of technical failure and investment to develop innovative products, an important consideration with such high failure rates in pharma R&D. Continue reading “Cost Saving: The trade-off that bites back” »

Working to Uncover the Mode of Action

Posted on March 2nd, 2017 by in Pharma R&D

The New Year has brought some new talent into the Myelo Therapeutics team. In January we welcomed Susann, our new postdoctoral researcher. We’re excited to have someone with her experience, which includes studying molecular biology in Dresden and Heidelberg, Continue reading “Working to Uncover the Mode of Action” »

Will 2017 be a Black Swan year?

Posted on February 6th, 2017 by in Pharma R&D

A few years ago, I sat with some friends aiming to make predictions for the year ahead. Our goal was to see how close we could get, with a plan to review the following new year. We made several predictions for the world of science Continue reading “Will 2017 be a Black Swan year?” »

5 most popular Pharma R&D blog posts of 2016

Posted on February 1st, 2017 by in Pharma R&D

The top blogs in this category reflect just how much politics and current events can mean to the health of the pharmaceutical industry, Continue reading “5 most popular Pharma R&D blog posts of 2016” »

  1. 1
  2. 2
  3. 3
  4. 4